Health equity research

Explore the most viewed and latest equity research and media content for companies within the Health sector. Companies working in the Health sector include pharmaceuticals, biotech firms, and medical equipment & service providers.

Health equity research

Explore the most viewed and latest equity research and media content for companies within the Health sector. Companies working in the Health sector include pharmaceuticals, biotech firms, and medical equipment & service providers.

Latest Content

VLS GSH EGI MSG FDEV UNG TND LTHM REDX CREO

Small Cap Breakfast

GYG—Intention to float by the superyacht painting, supply and maintenance company. Due 5 July. Raising £6.9m new plus vendor sale of £21.5m at 100p. Mkt Cap c. £47m. Revenue of €54.6m in FY16 and adjusted EBITDA of €6.7m. Greencoat Renewables - Schedule 1. Targeting a portfolio of operating renewable electricity generation assets, initially investing in wind generation assets in Ireland. Offer TBC. Due Mid July. FFI Holdings— Specialist in the provision of completion contracts to the entertainment industry for films, television, mini-series and streaming product. Offer TBA. Expected 30 June. QUIZ— Omni-channel fast fashion womenswear Company intention to float. Due July 2017. Offer TBA Ethernity Networks—Schedule 1 from Israeli based specialist in data processing technology used in high end carrier ethernet applications across the telecom, mobile, security and data centre markets. Expected late June. Offer TBA. Jangada Mines—Sch 1 advanced stage PGM exploration project containing what the Directors understand to be the largest PGM resource, and only pre-development PGM project, in South America. Offer TBA. Expected late June. Phoenix Global Mining— US Brown field copper play. Expected late June. Offer TBA Touchstone Exploration— Oil E&P company active in the Republic of Trinidad and Tobago. Interests of approximately 90k gross acres. Production c. 1.3k boepd. Raising £1.5m. Expected mkt cap £7.5m - 26 June. I3 Energy –Schedule 1. Independent oil and gas company with assets and operations in the UK. Offer TBC, 7 June admission. Verditek— Schedule 1 update. On Admission, the Company's subsidiaries will be involved in advanced solar photovoltaic, filtration and absorption technologies specialising in providing environmental services. Issue price 10p. Admission late June Tiso Blackstar Group—Schedule 1 update. Media, entertainment and marketing solutions group/ £160m mkt cap. Admission only. Postponed. Rockpool Acquisitions—Northern Ireland based Company seeking strong NI acquisition with an international outlook. Raising £1.5m at 10p. Due 5 July. Residential Secure Income - social housing REIT raising up to £300m Admission due c.12 July. ScotGems—Admission due 26 June. Seeking £50-£100m. To investing in a diversified portfolio of Small Cap Companies listed on global stock markets DP Eurasia—Intention to float from the exclusive master franchisee of the Domino's Pizza brand in Turkey, Russia, Azerbaijan and Georgia . £20m primary raise plus a partial vendor sale. AIB—Intention to float from AIB, Ireland's leading retail and commercial bank. The Minister for Finance intends to sell approximately 25% of the Ordinary Shares of AIB. Valuation range €10.6-€13.3bn. Admission end June. Curzon Energy—Report on Proactive Investors of intended LSE float this year with acquisition of coal bed methane assets in Oregon. Looking to raise £3m plus. NLB Group—financial and banking institution based in Slovenia, with a network of 356 branches. Seeking Ljubliana Stock Exchange listing with GDRs on the LSE. Expected mid June. Kuwait Energy— $150m raise plus vendor offer. Admission due June. 2p reserves 810.0 mmboe Supermarket Income REIT– Up to £200m raise to acquire a diversified portfolio of supermarket real estate assets in the UK, providing long-term RPI-linked income. Due 21 July.

  • 22 Jun 17
  • -
  • -

FAES Farma

Relying on M&A to revive momentum

Faes Farma reported a decent set of Q1 17 results, albeit with a more moderate sales growth than the previous quarters (in line with management’s cautious FY17 guidance). Total revenue was up 6.7% to €60.8m, with Bilastine remaining the key driver, offset to an extent by the continued weakness in Portugal and the animal nutrition business. Despite increased R&D efforts, profitability remained strong with EBIT and net profit registering a growth of c.14% (to €12.6m) and 15% (to €9.3m), respectively (run-rate slightly ahead of management guidance), driven by operating leverage and stringent input cost management. Management has announced a complementary dividend of €0.018 (in addition to the €0.9 scrip dividend) for FY 16, to be paid out in June 2017 (+18% growth over FY 15). Following through on its inorganic intent, Faes Farma announced the acquisition of Spain-based OTC pharma company, Laboratorios Diafarm, earlier this month for a consideration of c. €70m (1.4x EV/Sales, c.15x EV/EBITDA). The deal will be financed largely through the company’s cash balances (c.€55m net cash position at the end of 2016) and supplemented with bank financing. This comes after the acquisition of the remaining 50% stake in its Mexican JV, MIT Farma and Spanish animal nutrition company, Initial Technical Foods, in April 2017. We expect management to announce a guidance change in the coming quarters to factor in the acquisitions.

  • 22 Jun 17
  • -
  • -

Real-time access to the latest equity research, for the first time.

📑🔎📊📈

Historically, Private Investors have had access to significantly less professional investment research and information than institutions, funds, and banks. At Research Tree, we're trying level that playing field by aggregating the latest equity research & video content from 367 analysts at 31 city brokerages and research houses in one platform. 

 

Our goal is simple: provide retail and non-institutional investors with full access to the latest valuations, target prices, analysis, and financial models on the companies they care about, in real-time.

 

Our Partners

🏛

Research Tree aggregates the latest equity research from 367 analysts at 31 city brokerages and research houses in one platform, giving users full access to the latest valuations, target prices, analysis, and financial models on the companies they care about, in real-time.